Product Description
LUPRON DEPOT 11.25 is an anti-cancer medication which is available in the form of injections that can be directly injected into the human body for faster absorption which results in faster action. It is especially formulated for the treatment of the prostate cancer by regulating various processes within the body. It can also be used for the curing of endometrium of the uterus, uterine fibroids and central precocious puberty and provide relief from the symptoms like pain, heavy or irregular periods.
Indications and BenefitsLUPRON DEPOT 11.25 is prescribed for the management of hormone-dependent conditions such as prostate cancer, endometriosis, uterine fibroids, and precocious puberty. Its sustained-release technology enables reduced injection frequency, providing convenient three-month dosing while maintaining therapeutic hormone suppression. Patients benefit from fewer clinic visits and a stable, predictable release profile that supports effective disease management.
Administration ProcessThis medication is administered intramuscularly as a depot injection by a healthcare provider. The provided vial contains leuprorelin acetate in a lyophilized powder, which is reconstituted with a diluent prior to use. Proper technique and aseptic conditions are essential to ensure efficacy and patient safety. It is not for self-administration and must be handled by trained professionals in appropriate clinical settings.
Long-Lasting Formulation and StorageFeaturing a prolonged-release mechanism, LUPRON DEPOT 11.25 ensures continuous medication delivery over three months. The formulation is stable for 24 months when stored below 25C and protected from light. These storage conditions help maintain product integrity and efficacy, supporting its practical use for supply and logistics throughout India.
FAQs of LUPRON DEPOT 11.25:
Q: How should LUPRON DEPOT 11.25 be administered?
A: LUPRON DEPOT 11.25 is administered via intramuscular injection after the lyophilized powder is reconstituted with the provided diluent. It must only be injected by a qualified healthcare professional.
Q: What are the main indications for using LUPRON DEPOT 11.25?
A: This medication is indicated for treating prostate cancer, endometriosis, uterine fibroids, and precocious puberty by regulating hormone levels through a sustained-release action.
Q: When is the dosing of LUPRON DEPOT 11.25 typically repeated?
A: Due to its prolonged-release formulation, LUPRON DEPOT 11.25 is generally administered once every three months as part of the prescribed therapy regimen.
Q: Where should LUPRON DEPOT 11.25 be stored prior to use?
A: The product should be stored below 25C and protected from light to preserve its stability and effectiveness. Avoid exposure to high temperatures or direct sunlight.
Q: What are the benefits of the depot injection formulation?
A: The depot formulation provides sustained hormone suppression over three months, reducing the need for frequent injections and supporting consistent therapeutic outcomes.
Q: What precautions should be taken before using LUPRON DEPOT 11.25?
A: Individuals with a known hypersensitivity to leuprolide acetate or similar compounds must not use this medication. A healthcare provider will assess suitability prior to treatment initiation.